Innovation Medical Management Co., Ltd. (002173.SZ)
CNY 12.41
(10.02%)
CNY 12.41
(10.02%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 410.38 Million CNY | -5.53% |
| 2022 | 434.41 Million CNY | -23.15% |
| 2021 | 565.26 Million CNY | 6.03% |
| 2020 | 533.1 Million CNY | 7.03% |
| 2019 | 498.11 Million CNY | -23.22% |
| 2018 | 648.73 Million CNY | -34.75% |
| 2017 | 994.23 Million CNY | -3.94% |
| 2016 | 1.03 Billion CNY | 56.89% |
| 2015 | 659.7 Million CNY | 17.35% |
| 2014 | 562.19 Million CNY | 2.27% |
| 2013 | 549.69 Million CNY | 11.57% |
| 2012 | 492.67 Million CNY | 12.08% |
| 2011 | 439.56 Million CNY | 11.58% |
| 2010 | 393.92 Million CNY | 6.59% |
| 2009 | 369.58 Million CNY | 39.21% |
| 2008 | 265.47 Million CNY | 5.69% |
| 2007 | 251.18 Million CNY | 4.05% |
| 2006 | 241.4 Million CNY | 60.1% |
| 2005 | 150.78 Million CNY | 142.52% |
| 2004 | 62.17 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 376.6 Million CNY | -4.71% |
| 2024 Q1 | 396.17 Million CNY | -3.46% |
| 2024 Q2 | 395.21 Million CNY | -0.24% |
| 2023 FY | 410.38 Million CNY | -5.53% |
| 2023 Q4 | 410.38 Million CNY | 2.71% |
| 2023 Q3 | 399.55 Million CNY | 10.99% |
| 2023 Q2 | 359.99 Million CNY | -15.22% |
| 2023 Q1 | 424.63 Million CNY | -2.25% |
| 2022 Q2 | 449.11 Million CNY | -4.2% |
| 2022 Q3 | 373.24 Million CNY | -16.89% |
| 2022 Q1 | 468.82 Million CNY | -17.06% |
| 2022 FY | 434.41 Million CNY | -23.15% |
| 2022 Q4 | 434.41 Million CNY | 16.39% |
| 2021 Q2 | 517.26 Million CNY | -12.16% |
| 2021 Q3 | 540.64 Million CNY | 4.52% |
| 2021 Q4 | 565.26 Million CNY | 4.55% |
| 2021 FY | 565.26 Million CNY | 6.03% |
| 2021 Q1 | 588.84 Million CNY | 10.46% |
| 2020 FY | 533.1 Million CNY | 7.03% |
| 2020 Q4 | 533.1 Million CNY | 18.56% |
| 2020 Q1 | 462.07 Million CNY | -7.23% |
| 2020 Q3 | 449.63 Million CNY | 4.22% |
| 2020 Q2 | 431.43 Million CNY | -6.63% |
| 2019 Q2 | 571.4 Million CNY | -8.81% |
| 2019 FY | 498.11 Million CNY | -23.22% |
| 2019 Q4 | 498.11 Million CNY | 14.98% |
| 2019 Q3 | 433.21 Million CNY | -24.18% |
| 2019 Q1 | 626.59 Million CNY | -3.41% |
| 2018 Q3 | 1.29 Billion CNY | 17.21% |
| 2018 Q4 | 648.73 Million CNY | -49.74% |
| 2018 Q1 | 1.01 Billion CNY | 1.64% |
| 2018 Q2 | 1.1 Billion CNY | 8.98% |
| 2018 FY | 648.73 Million CNY | -34.75% |
| 2017 Q2 | 1.13 Billion CNY | 14.15% |
| 2017 FY | 994.23 Million CNY | -3.94% |
| 2017 Q4 | 994.23 Million CNY | -4.22% |
| 2017 Q3 | 1.03 Billion CNY | -8.16% |
| 2017 Q1 | 990.15 Million CNY | -4.34% |
| 2016 Q1 | 1.36 Billion CNY | 106.42% |
| 2016 Q4 | 1.03 Billion CNY | -3.59% |
| 2016 Q3 | 1.07 Billion CNY | -13.68% |
| 2016 Q2 | 1.24 Billion CNY | -8.67% |
| 2016 FY | 1.03 Billion CNY | 56.89% |
| 2015 Q2 | 551.41 Million CNY | -3.33% |
| 2015 Q1 | 570.4 Million CNY | 1.46% |
| 2015 FY | 659.7 Million CNY | 17.35% |
| 2015 Q3 | 564.05 Million CNY | 2.29% |
| 2015 Q4 | 659.7 Million CNY | 16.96% |
| 2014 FY | 562.19 Million CNY | 2.27% |
| 2014 Q3 | 556.98 Million CNY | -6.24% |
| 2014 Q2 | 594.07 Million CNY | 4.13% |
| 2014 Q1 | 570.48 Million CNY | 3.78% |
| 2014 Q4 | 562.19 Million CNY | 0.94% |
| 2013 FY | 549.69 Million CNY | 11.57% |
| 2013 Q4 | 549.69 Million CNY | -5.67% |
| 2013 Q3 | 582.76 Million CNY | 13.08% |
| 2013 Q2 | 515.35 Million CNY | 3.64% |
| 2013 Q1 | 497.27 Million CNY | 0.93% |
| 2012 Q3 | 437.7 Million CNY | -4.75% |
| 2012 Q1 | 451.24 Million CNY | 2.66% |
| 2012 FY | 492.67 Million CNY | 12.08% |
| 2012 Q4 | 492.67 Million CNY | 12.56% |
| 2012 Q2 | 459.54 Million CNY | 1.84% |
| 2011 FY | 439.56 Million CNY | 11.58% |
| 2011 Q4 | 439.56 Million CNY | 9.83% |
| 2011 Q1 | 474.11 Million CNY | 20.35% |
| 2011 Q3 | 400.23 Million CNY | -12.93% |
| 2011 Q2 | 459.67 Million CNY | -3.05% |
| 2010 Q1 | 422.39 Million CNY | 14.29% |
| 2010 FY | 393.92 Million CNY | 6.59% |
| 2010 Q4 | 393.92 Million CNY | -2.97% |
| 2010 Q3 | 406 Million CNY | -1.8% |
| 2010 Q2 | 413.45 Million CNY | -2.12% |
| 2009 Q3 | 358.22 Million CNY | 19.05% |
| 2009 Q2 | 300.89 Million CNY | 4.96% |
| 2009 Q1 | 286.66 Million CNY | 7.98% |
| 2009 FY | 369.58 Million CNY | 39.21% |
| 2009 Q4 | 369.58 Million CNY | 3.17% |
| 2008 Q4 | 265.47 Million CNY | 1.82% |
| 2008 FY | 265.47 Million CNY | 5.69% |
| 2008 Q1 | 318.25 Million CNY | 26.7% |
| 2008 Q2 | 290.69 Million CNY | -8.66% |
| 2008 Q3 | 260.74 Million CNY | -10.3% |
| 2007 Q2 | 183.13 Million CNY | 0.0% |
| 2007 FY | 251.18 Million CNY | 4.05% |
| 2007 Q4 | 251.18 Million CNY | -3.46% |
| 2007 Q3 | 260.18 Million CNY | 42.07% |
| 2006 Q4 | 241.4 Million CNY | 0.0% |
| 2006 FY | 241.4 Million CNY | 60.1% |
| 2005 FY | 150.78 Million CNY | 142.52% |
| 2004 FY | 62.17 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Chow Tai Seng Jewellery Co., Ltd. | 1.62 Billion CNY | 74.717% |
| Guangdong Chj Industry Co.,Ltd. | 1.91 Billion CNY | 78.625% |
| Beijing Kingee Culture Development Co., Ltd. | 141.36 Million CNY | -190.297% |